Increasing evidences suggest that PRDX6 is involved in the pathogenesis of atherosclerosis and T2DM, but its role in the etiopathology of obesity and its complications is still not known. This evidence concerns the gene PRDX6 and obesity due to melanocortin 4 receptor deficiency.